TD BUY $1737.TW at 33.40, Supp 32.90 Resis 35.00 R6 HiLo 65% none PE 14.5 DIV 4.34% #TAIYEN BIO #Taiwan #trading #stocks

2019-06-13
64 Views

TD BUY detected for 1737.TW (TAIYEN BIOTECH CO) at the close price of 33.40 with a support level at 32.90 and a resistance at 35.00, providing an opportunity for a 6 % return. Trading at a 65 % level between the 52week High (35.90) and 52 week Low (28.75). The average analyst 1-year target price is 0.0 with an average none and a score of 0.0.

TD Buy
6 %
1737.TW
33.40
TAIYEN BIOTECH CO
HiLo
65.0 %
Support
32.90
Resistance
35.00
Target1Y
0.00
Rated
none
Score
0.0
52week high
35.90
52week low
28.75
50DMA
32.65
200DMA
30.94
10DMA
33.91
20DMA
33.94
100DMA
31.77
Volume
351000
AvgDayVol
403596
MarketCap
6680000512
EBITDA
587093504
Revenue
2996122112
PE
14.52
P2S
2.23
P2B
0.00
Dividend
1.50
Div Ex-Date
2018-08-16 00:00:00

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

#GoldenCross $G1A.DE at 26.67 R7  HiLo 54% none PE 47.9 DIV 3.21% #GEA GROUP  #DAX #Aktien #Boerse #stocks
Bull, Europe, Germany
13 views
Bull, Europe, Germany
13 views

#GoldenCross $G1A.DE at 26.67 R7 HiLo 54% none PE 47.9 DIV 3.21% #GEA GROUP #DAX #Aktien #Boerse #stocks

Andreas Aigner - 2019-09-19

Golden Cross detected for G1A.DE (GEA GROUP AG) at the close price of 26.67. Trading at a 54 % level…

TD SELL $DLG.L at 305.40, Supp 279.90 Resis 305.40 R9  HiLo 30% T1Y 380 none PE 9.8 DIV 7.01% #DIRECT LIN #UK #LSE #London #stocks #trading
Bear, Europe, Financial Services
9 views
Bear, Europe, Financial Services
9 views

TD SELL $DLG.L at 305.40, Supp 279.90 Resis 305.40 R9 HiLo 30% T1Y 380 none PE 9.8 DIV 7.01% #DIRECT LIN #UK #LSE #London #stocks #trading

Andreas Aigner - 2019-09-19

TD SELL detected for DLG.L (DIRECT LINE INSURANC) at the close price of 305.40 with a support level at 279.90…

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.